LAPTOP (NEAT44) – The Late Presenter Treatment Optimisation Study  

An Open-Label, Multi-Centre, Randomised Study to Investigate Integrase Inhibitor Versus Boosted Protease Inhibitor Antiretroviral Therapy for Patients with Advanced HIV-Disease 

 

SPONSOR: NEAT ID Foundation 

 

Sponsor code: NEAT44 

EudraCT: 2018-003481-13 

 

Phase:  III

 

Indication:  ART-naïve HIV-1 infected patients

 

Countries: UK, France, Germany, Belgium, Spain, Italy, Ireland, Ukraine

 

Status:  Actively recruiting

Administrative office: NEAT ID Foundation, 27 Old Gloucester Street, London WC1N 3AX, UK

     e: NEAT-ID@NEAT-ID.org     

w: www.NEAT-ID.org

Registered address: PL 709  Rue Haute 322, 1000 Brussels, Belgium

©NEAT ID 2019